Use of Stromal Vascular Fraction in Multiple Sclerosis
Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis
Sponsor: Global Alliance for Regenerative Medicine
A NA clinical study on Autoimmune and Multiple Sclerosis, this trial is suspended. The trial is conducted by Global Alliance for Regenerative Medicine and has accumulated 16 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
16 versions recorded-
Oct 2025 — Present [monthly]
Suspended NA
-
Sep 2025 — Oct 2025 [monthly]
Suspended NA
-
Oct 2024 — Sep 2025 [monthly]
Suspended NA
-
Sep 2024 — Oct 2024 [monthly]
Suspended NA
-
Jul 2024 — Sep 2024 [monthly]
Suspended NA
▶ Show 11 earlier versions
-
Sep 2022 — Jul 2024 [monthly]
Suspended NA
-
Dec 2021 — Sep 2022 [monthly]
Suspended NA
-
Feb 2021 — Dec 2021 [monthly]
Suspended NA
Status: Enrolling By Invitation → Suspended
-
Jan 2021 — Feb 2021 [monthly]
Enrolling By Invitation NA
-
Feb 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
-
Sep 2019 — Feb 2020 [monthly]
Enrolling By Invitation NA
-
Feb 2019 — Sep 2019 [monthly]
Enrolling By Invitation NA
-
Dec 2018 — Feb 2019 [monthly]
Enrolling By Invitation NA
-
Sep 2018 — Dec 2018 [monthly]
Enrolling By Invitation NA
Status: Active Not Recruiting → Enrolling By Invitation
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Global Alliance for Regenerative Medicine
- Healeon Medical Inc
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Roatán, Honduras
- • Stevensville, United States